Sie befinden sich hier

Inhalt

Publikationen

2016

Nicolay JP, Wobser M. Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy. J Dtsch Dermatol Ges. 2016; 14: 1207-1224.

Nicolay JP, Schneider S, Gaiser T, Felcht M, Klemke CD. Differential expression of cancer stem cell markers in cutaneous and systemic lymphoma. Exp Dermatol. 2016; 25: 561-3.

Nicolay JP, Muller-Decker K, Schroeder A, Brechmann M, Mobs M, Geraud C, Assaf C, Goerdt S, Krammer PH, Gulow K. Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-kappaB. Blood. 2016; 128: 805-15.

Nicolay JP, Felcht M, Schledzewski K, Goerdt S, Geraud C. Sezary syndrome: old enigmas, new targets. J Dtsch Dermatol Ges. 2016; 14: 256-64.

2015

Teichert M, Stumpf C, Booken N, Wobser M, Nashan D, Hallermann C, Mogler C, Muller CS, Becker JC, Moritz RK, Andrulis M, Nicolay JP, Goerdt S, Thomas M, Klemke CD, Augustin HG, Felcht M. Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis. Exp Dermatol. 2015; 24: 424-9.

Ruggiero E*, Nicolay JP*, Fronza R, Arens A, Paruzynski A, Nowrouzi A, Urenden G, Lulay C, Schneider S, Goerdt S, Glimm H, Krammer PH, Schmidt M, von Kalle C. High-resolution analysis of the human T-cell receptor repertoire. Nat Commun. 2015; 6: 8081. *contributed equally

Klemke CD, Booken N, Weiss C, Nicolay JP, Goerdt S, Felcht M, Geraud C, Kempf W, Assaf C, Ortonne N, Battistella M, Bagot M, Knobler R, Quaglino P, Arheiliger B, Santucci M, Jansen P, Vermeer MH, Willemze R. Histopathological and immunophenotypical criteria for the diagnosis of Sezary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. Br J Dermatol. 2015; 173: 93-105.

2014

Nicolay JP, Klemke CD. [Management of cutaneous lymphomas]. Hautarzt. 2014; 65: 607-13.

2013

Booken N, Nicolay JP, Weiß C, Goerdt S, Klemke CD. Cutaneous tumour cell load correlates with survival in patients with Sézary syndrome. J Dtsch Dermatol Ges. 2013 Jan;11(1):67-79.

2012

Felcht M, Heck M, Weiss C, Becker JC, Dippel E, Müller CS, Nashan D, Sachse MM, Nicolay JP, Booken N, Goerdt S, Klemke CD. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumor cells. Br J Dermatol. 2012 Aug;167(2):348-58..

Booken N, Goerdt S, Klemke CD. Clinical spectrum of primary cutaneous CD30-positive anaplastic large cell lymphoma: an analysis of the Mannheim Cutaneous Lymphoma Registry. J Dtsch Dermatol Ges. 2012 May;10(5):331-9.

Brechmann M, Mock T, Nickles D, Kiessling M, Weit N, Breuer R, Muller W, Wabnitz G, Frey F, Nicolay JP, Booken N, Samstag Y, Klemke CD, Herling M, Boutros M, Krammer PH, Arnold R. A PP4 holoenzyme balances physiological and oncogenic nuclear factor-kappa B signaling in T lymphocytes. Immunity. 2012; 37: 697-708.

2011

Felcht M, Booken N, Stroebel P, Goerdt S, Klemke CD. The value of molecular diagnosis and molecular staging in primary cutaneous B-cell lymphomas. J Am Acad Dermatol 2011 Jan;64(1):135-43.

Booken N, Heck M, Nicolay JP, Klemke CD, Goerdt S, Utikal J. Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma. Br J Dermatol. 2011 Mar;164(3):665-7.

Klemke CD. Systemic treatment of cutaneous lymphomas. Hautarzt. 2011 Jun;62(6):436-43.

2010

Booken N, Weiß C, Utikal J, Felcht M, Goerdt S, Klemke CD. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome. J Dtsch Dermatol Ges. 2010 Jun;8(6):428-38.

2009

Kiessling M, Klemke CD, Kamiński M, Galani I, Krammer PH, Gülow K. Inhibition of NF-κB induces Iron- and ROS-dependent Cell Death by downregulation of Ferritin Heavy Chain in T cell lymphoma. Cancer Res. 2009;69:2365-74.

Klemke CD, Brenner D, Weiß EM, Schmidt M, Leverkus M, Gülow K, Krammer PH. The lack of T cell receptor induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T cell lymphoma cells from Activation-Induced Cell Death. Cancer Res. 2009;69:4175-4183.

Heid JB, Schmidt A, Oberle N, Goerdt S, Krammer PH, Suri-Payer E, Klemke CD. FOXP3+CD25- tumor cells with regulatory function in Sézary Syndrome. J Invest Dermatol 2009;129:2875-85.

2008

Booken N, Gratchev A, Utikal J, Weiß C, Yu X, Qadoumi M, Schmuth M, Sepp N, Nashan D, Rass K, Tüting T, Assaf C, Dippel E, Stadler R, Klemke CD, Goerdt S. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3. Leukemia. 2008;22:393-9.

Stadler R, Assaf C, Klemke CD, Nashan D, Weichenthal M, Dummer R, Sterry W. Kurzleitlinie – Kutane Lymphome. J Dtsch Dermatol Ges. 2008;6 (Supplement 1):S29-S35.

Klemke CD, Brade J, Weckesser S, Sachse MM, Booken N, Neumaier M, Goerdt S, Nebe TC. Diagnosis and follow-up of blood involvement in patients with Sézary syndrome. Br J Dermatol. 2008;159(4):871-80.

Klemke CD. Mykosis fungoides. CME Dermatologie 2008;3:106-122.

2006

Utikal J, Poenitz N, Gratchev A, Klemke CD, Nashan D, Tüting T, Goerdt S. Additional Her 2/neu gene copies in patients with Sézary syndrome. Leuk Res. 2006 30(6):755-60.

Klemke CD, Poenitz N, Dippel E, Hummel M, Stein H, Goerdt S. T-cell clonality of undetermined significance. Arch Dermatol 2006;142:393-394.

Klemke CD, Fritzsching B, Franz B, Kleinmann E, Oberle N, Poenitz N, Sykora J, Banham AH, Roncador G, Goerdt S, Krammer PH, Suri-Payer E. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary Syndrome from other cutaneous T cell lymphomas. Leukemia 2006;20:1123-9.

Klemke CD, Goerdt S, Schrama D, Becker JC. Kutanes T-Zell Lymphom: Von der Molekularbiologie zur zielgerichteten Therapie. J Dtsch Dermatol Ges. 2006;4:395-405.

2005

Klemke CD, Mansmann U, Poenitz N, Dippel E, Goerdt S. Prognostic factors and prediction of prognosis by the CTCL-Severity Index in mycosis fungoides and Sézary syndrome. Br J Dermatol 2005;153:118-24.

Poenitz N, Simon-Ackermann J, A. Gratchev A, Qadoumi M, Klemke CD, Stadler R, Kremer A, Radenhausen M, Henke U, Assaf C, Utikal J, Goerdt S, Dippel E. Overexpression of c-myb in leukemic and non-leukemic variants of cutaneous T-cell lymphoma. Dermatology 2005;211:84-92.

2003

Poenitz N, Dippel E, Klemke CD, Qadoumi M, Goerdt S. Jessner’s lymphocytic infiltration of the skin: a CD8+ polyclonal reactive skin condition. Dermatology. 2003;207:276-84.

2002

Klemke CD, Dippel E, Dembinski A, Ponitz N, Assaf C, Hummel M, Stein H, Goerdt S. Clonal T cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides. J Pathol. 2002;197:348-54.

2001

Dippel E, Klemke CD, Hummel M, Stein H, Goerdt S. T-cell clonality of undetermined significance. Blood 2001;98:247-8.

Kontextspalte